How to treat Prostate cancer?

Kä bɛ kanthɛr pröthɛt ciɛŋ i̱di̱?

Tëë kɛ dup ti̱ ŋuan ti̱ dëë lät kɛ kui̱i̱ jua̱th pröthɛt kancer, kä jɛn bɛ tekä ta̱a̱ in te kancer thi̱n kɛnɛ ta̱a̱ in ci̱ jɛ wɔ̱, amäni̱ ta̱a̱ puɔlä pua̱a̱ny ran kɛnɛ tin go̱o̱rɛ.

Tha̱a̱ŋ jua̱thni̱ tin laa lät kɛ jɛ laa:

1. Guäc mi̱ gɔaa: Guäc ɛmɛ lotdɛ ni̱ guäc kɛ̈ɛ̈l kɛ̈ɛ̈li̱ kɛ kui̱ kanthɛr kɛ guäc kɛnɛ thëm gua̱thni̱ diaal, ɛ /ci̱e̱ mi̱ bi̱ tuɔk kɛ mi̱ dëë tok kɛ mi̱ dëë lät kɛ jɛ.

Jɛn derɛ rɔ lot kɛ wutni̱ tin tekɛ juey pröthɛt kancer mi̱ kuiy jueydiɛn.

2. Ɣɔ̱ɔ̱r: Pröthɛtektomi̱ ɛ la̱t mi̱ la̱tkɛ kɛ ɣöö ba pröthɛt gland woc.

Jɛn derɛ la̱t kɛ duɔ̱ɔ̱p la̱t mi̱ te raar kiɛ laparöthkɔpik (la̱t kɛ mi̱ tɔt mi̱ ca ŋok kɛnɛ kuak ti̱ gööl).

3. radiation therapy: Nɛmɛ laa jɛ laa laa laa̱tkɛ kɛ radiation mi̱ di̱i̱t kɛ ɣöö baa thɛl kanthɛr näk.

Jɛn derɛ la̱th raar (ɛ ji̱e̱k raar rɛy pua̱a̱ny) kiɛ rɛy pua̱a̱ny (ɛ la̱thkɛ jɛ thi̱n ɛ thia̱k kɛ tuɔmɛr).

4. Ɣɔrmɔɔn tɛrapi: Ɛn ta̱a̱ in laa tä kɛ wal ɛmɛ laa jakɛ ni̱ ɣöö bi̱ nämbäri̱ wutni̱ tin laa tä rɛy pua̱a̱ny ran (androgens) wä piny, kä nɔmɔ laa jakɛ ni̱ kanthɛr in tä rɛy pua̱a̱ny ran kä kuiy kiɛ laa jakɛ ni̱ jɛ kä /cɛ rɔ bi̱ rep.

De jɛ lät kärɔa kiɛ mat kɛ wal kɔ̱kiɛn.

5. Chemotherapy: Ɛn ca̱p ɛmɛ laa lätkɛ ni̱ wal ti̱ laa näk thëlli̱ kanthɛr.

Jɛn derɛ lät kɛ kui̱ pröthɛtik kanthɛr mi ci̱ räth kä ci̱ däk kä tha̱a̱ŋ pua̱a̱nyni̱ kɔ̱kiɛn.

6. Immunotherapy: Nɛmɛ luäk kɛ ga̱ŋ pua̱a̱ny kä ɣöö bɛ juey köök.

Jɛn derɛ lät kɛ kui̱ pröthɛtik kancer mi̱ ci̱ räth mi̱ /kenɛ loc kä ki̱i̱mni̱ kɔ̱kiɛn.

7.Therapy mi̱ ca riali̱kä: Nɛmɛ ɛ mi̱ la̱tkɛ kɛ ji̱i̱ni̱ tin ca lɛy kiɛ pröti̱i̱ni̱ tin luäk thëlli̱ kanthɛrä kɛ piith kɛnɛ tëkdiɛn.

Jɛn derɛ lät kɛ kui̱ pröthɛtik kancer mi̱ ci̱ räth mi̱ /kenɛ loc kä ki̱i̱mni̱ kɔ̱kiɛn.

8. Kri̱ötherapi̱: Ɛn la̱t ɛmɛ lätdɛ kɛ kɔ̱c mi̱ di̱i̱t kɛ ɣöö bɛ thɛl kanthɛr yi̱r kä bɛ jɛ näk.

Jɛn derɛ lät kɛ kui̱ kanthɛr pröthɛta mi̱ ŋot kɛ tukdɛ kiɛ kɛ kui̱ kanthɛr mi̱ ci̱ rɔ nyɔk kɛ ben kɛ kɔr kä mëë ci̱ kɛnɛ kuɛn.

9. High-intɛnthi̱ti̱th (HIFU): Nɛmɛ laa lätdɛ kɛ jɔw mi̱ di̱i̱t mi̱ laa jiɛthkɛ kä laa däkɛ thëlli̱ kanthɛrä.

Jɛn derɛ lät kɛ kui̱ kanthɛr pröthɛta mi̱ ŋot kɛ tukdɛ kiɛ kɛ kui̱ kanthɛr mi̱ ci̱ rɔ nyɔk kɛ ben kɛ kɔr kä mëë ci̱ kɛnɛ kuɛn.

10. Guic kɛ guic: Nɛmɛ lotdɛ ni guic kɛ guic kɛ juey kɛ guic ni ciaŋ kɛnɛ thɛm, duŋni̱ ɣöö /ca jɛ bi̱ tok kɛ mi̱ ca jek ɛ ni̱ mi̱ ci̱ nyuuthni̱ jɛ jɔɔc kiɛ ci̱ rɔ̱ gɛr.

Jɛn derɛ rɔ lot kɛ wutni̱ tin di̱t tin tekɛ kanthɛr pröthɛta mi̱ /ci̱ piith ɛlɔ̱ŋ kɛnɛ jua̱th kɔ̱kiɛn ti̱ bɛc.

Jɛn ɛ mi̱ di̱i̱t ɛn ɣöö bi̱ ruac kɛ kui̱i̱ kä tin dëë lät kɛ ji̱ jua̱thni̱ diaal kɛ ɣöö bi̱ kɛ jiek kɛ min gɔaa ni̱ jɛn kɛ kui̱i̱ kä min bi̱ tuɔɔk kä ramɔ.

['Kuënɛ']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Wang Y, Chen J, Wu Z, Ding W, Gao S, Gao Y, Xu C: Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it. Br J Pharmacol. 2021, 178 (2): 239-261.

Talkar SS, Patravale VB: Gene Therapy for Prostate Cancer: A Review. Endocr Metab Immune Disord Drug Targets. 2021, 21 (3): 385-396.

Šamija I, Fröbe A: CHALLENGES IN MANIPULATING IMMUNE SYSTEM TO TREAT PROSTATE CANCER. Acta Clin Croat. 2019, 58 (Suppl 2): 76-81.

Akaza H, Hinotsu S, Usami M, Ogawa O, Kagawa S, Kitamura T, Tsukamoto T, Naito S, Hirao Y, Murai M, Yamanaka H, Namiki M: The case for androgen deprivation as primary therapy for early stage disease: results from J-CaP and CaPSURE. J Urol. 2006, 176 (6 Pt 2): S47-9.

Abraham-Miranda J, Awasthi S, Yamoah K: Immunologic disparities in prostate cancer between American men of African and European descent. Crit Rev Oncol Hematol. 2021, 164 (): 103426.

de Vrij J, Willemsen RA, Lindholm L, Hoeben RC, Bangma CH, Barber C, Behr JP, Briggs S, Carlisle R, Cheng WS, Dautzenberg IJ, de Ridder C, Dzojic H, Erbacher P, Essand M, Fisher K, Frazier A, Georgopoulos LJ, Jennings I, Kochanek S, Koppers-Lalic D, Kraaij R, Kreppel F, Magnusson M, Maitland N, Neuberg P, Nugent R, Ogris M, Remy JS, Scaife M, Schenk-Braat E, Schooten E, Seymour L, Slade M, Szyjanowicz P, Totterman T, Uil TG, Ulbrich K, van der Weel L, van Weerden W, Wagner E, Zuber G: Adenovirus-derived vectors for prostate cancer gene therapy. Hum Gene Ther. 2010, 21 (7): 795-805.

Lee E, Ha S, Logan SK: Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells. PLoS One. 2015, 10 (10): e0141589.

['Lät kɛ kui̱i̱ jua̱thni̱']

['Ɛn wɛbthaay ɛmɛ ca la̱th lät kɛ kui̱ ŋi̱i̱cä kɛnɛ läri kä /cɛ lot ni ɣöö ba ji̱ moc kɛ luäk ki̱mä kiɛ lät ti̱ gööl.']

['Lät kɛ läri tin ca ŋun /ca kɛ bi̱ lät kɛ ɣöö ba jua̱th jek kiɛ ba kɛ ciɛŋ, kä nɛy tin görkɛ luäk ki̱mädiɛn kärɔ̱ ba kɛ thiec kä ki̱m mi̱ tekɛ luäk ki̱mä.']

['Guic ɛ gɔaa ɛn ɣöö ɛn neural net min jak luɔc kä thie̱cni̱, /cɛ thuɔ̱k ɛlɔ̱ŋ mi̱ ci̱ ben kä nämbäri̱ tin te thi̱n. cetkɛ pek nath tin ca jek kɛ juey mi̱ rɛlrɔ.']

['Ni ciaŋ go̱ri ruac kä ki̱mdu kiɛ ram in kɔ̱ŋ mi ŋäc luäk pua̱a̱ny kɛ kui̱ jua̱thdu. /Cu ruac ki̱mdu car kiɛ jääny kɛ go̱ri kɛ kui̱ kä mi ci kuɛn kä wɛbthaay ɛmɛ. Mi caari jɛ ɛn ɣöö deri tekɛ juey mi go̱o̱ri luäk, cɔl 911 kiɛ wër guäth in thia̱k kɛ ji kɛ pɛ̈th. /Thilɛ maar kam ki̱m kɛnɛ juey mi bi̱ tuɔɔk kɛ kui̱ kä wɛbthaay ɛmɛ kiɛ la̱tdɛ. /Ci̱ BioMedLib kiɛ la̱a̱tkɛ, kiɛ ram in gɔ̱a̱r kɛ kui̱ kä wɛbthaay ɛmɛ, bi̱ ruac lat, kiɛ bi̱ ruac lat, kɛ kui̱ läri tin ca ka̱m raar rɛydɛ kiɛ la̱tdɛ.']

['Lät kɛ: ŋuɔ̱t']

['Ɛn Digital Millennium Copyright Act 1998, 17 U.S.C. § 512 (ɛ DMCA) ɛ ŋuɔ̱t mi̱ ŋun ji̱ cuŋni̱ tin ŋääth kɛn ɣöö ci̱ ŋɔaani̱ tin te kä intɛrnɛt ŋuɔ̱tkiɛn to̱l kɛ kui̱ ŋuɔ̱tni̱ cuŋni̱ tin te kä U.S.']

['Mi ca ji̱ ŋäth kɛ thuɔ̱k ɛn ɣöö tëëkɛ mi̱ ca gɔ̱r kiɛ mi̱ ca ka̱m ji̱ rɛy wɛbthaayäda kiɛ lät tin kɔ̱ŋ tin ci̱ ŋuɔ̱t tin ca gɔ̱r ya̱r, ji̱n (kiɛ ram in lät kɛ kui̱du) deri̱ kɔ jäk kä warɛgak mi̱ bi̱ ji̱ thiec ɛn ɣöö ba min ca gɔ̱r kiɛ min ca gɔ̱r woc, kiɛ ba duɔ̱ɔ̱r la̱t kɛ ɣöö bi̱ ji̱ cop thi̱n.']

['Kɛn läri̱ ba kɛ jäk kɛ wargak ɛ la i̱thtäm (guic ni̱ gua̱th in ci̱ i̱thtäm in ca gɔ̱r "Kɔntak" kɛ kui̱ i̱thtäm in ci̱ jäk).']

['DMCA go̱o̱rɛ ɣöö bi̱ ji̱n warɛgakdu lat kɛ kui̱ kä tin ca lar i̱ ci̱ ŋuɔ̱t gɛr kɛ kui̱i̱ ŋuɔ̱tni̱ gɔ̱rä mat thi̱n kɛ läär ti̱ti̱: (1) latdɛ kɛ kui̱i̱ la̱t in ca gɛr kɛ kui̱i̱ ŋuɔ̱tni̱ gɔ̱rä min ca lar i̱ ca gɛr; (2) latdɛ kɛ kui̱i̱ kä tin ca lar i̱ ci̱ ŋuɔ̱t gɛr kɛnɛ läär ti̱ ro̱ŋ kɛ ɣöö bi̱ kɔn kɛ jek; (3) läri̱ kɛ kui̱i̱ kä min dëë ji̱ luäk kɛ jek, amäni̱ ci̱ötdu, nämbärɛ kä tin ci̱ ji̱ luäk kɛ jek, kɛnɛ emaildu; (4) latdu kɛ ɣöö ci̱ ji̱n ɛ ŋa̱c ɛn ɣöö min ca gɔ̱r kɛ kui̱i̱ kä tin ca lar /ci̱kɛ bi̱ lät kɛ luäkdɛ ɛ gua̱n ŋuɔ̱tni̱ gɔ̱rä, kiɛ ɛ la̱tdɛ, kiɛ kɛ luäk ŋuɔ̱tni̱; ']

['(5) mi ci ji gɔr piny kɛ kuic kä ɣöö bi ji ruac kɛ thuɔ̱k, ɛn ɣöö läri tin ca gɔr ɛ thuɔ̱k kä te ji kɛ lua̱ŋ kɛ ɣöö bi yiöw tin ca gɔr piny tin ca lar ɛ ji̱n ka̱m raar;']

['kɛnɛ (6) mi̱ ca gɔ̱r piny ɛ gua̱n ŋuɔ̱tni̱ kiɛ ram mi̱ tekɛ lua̱ŋ kɛ lät kɛ kui̱dɛ.']

['Mi /kenɛ läri tin ca lat nhial diaal mat thi̱n dɔ̱ŋ derɛ ku lɛ wɔ̱ jɔ̱ɔ̱r kɛ lätni̱ kɛ kɛ.']

['Röm kɛ jɛ']

['Thiecɛ kɔ kɛ email kɛ thiecni kiɛ cär.']

How to treat prostate cancer?

There are several treatment options available for prostate cancer, depending on the stage and aggressiveness of the cancer, as well as the patient's overall health and personal preferences.

Some common treatments include:

1. Active surveillance: This approach involves closely monitoring the cancer with regular checkups and tests, rather than immediately starting treatment.

It may be suitable for men with low-risk prostate cancer.

2. Surgery: A prostatectomy is a surgical procedure to remove the prostate gland.

It can be done through open surgery or laparoscopically (using small incisions and specialized tools).

3. Radiation therapy: This treatment uses high-energy radiation to kill cancer cells.

It can be delivered externally (from a machine outside the body) or internally (through implants placed near the tumor).

4. Hormone therapy: This treatment reduces the levels of male hormones (androgens) in the body, which can slow or stop the growth of prostate cancer.

It can be used alone or in combination with other treatments.

5. Chemotherapy: This treatment uses drugs to kill cancer cells.

It may be used for advanced prostate cancer that has spread to other parts of the body.

6. Immunotherapy: This treatment helps the immune system fight cancer.

It may be used for advanced prostate cancer that has not responded to other treatments.

7. Targeted therapy: This treatment targets specific genes or proteins that help cancer cells grow and survive.

It may be used for advanced prostate cancer that has not responded to other treatments.

8. Cryotherapy: This treatment uses extreme cold to freeze and kill cancer cells.

It may be used for early-stage prostate cancer or for cancer that has come back after other treatments.

9. High-intensity focused ultrasound (HIFU): This treatment uses high-frequency sound waves to heat and destroy cancer cells.

It may be used for early-stage prostate cancer or for cancer that has come back after other treatments.

10. Watchful waiting: This approach involves closely monitoring the cancer with regular checkups and tests, but not starting treatment unless symptoms appear or change.

It may be suitable for older men with slow-growing prostate cancer and other serious health conditions.

It is important to discuss all treatment options with a healthcare team to determine the best course of action for each individual case.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.